Net Loss per Share (Tables)

12 Months Ended

Dec. 31, 2023

Earnings Per Share [Abstract]

Schedule of Antidilutive Shares Excluded From Calculation of Diluted Net Loss Per Share

The following table presents the potentially dilutive shares that were excluded from the computation of diluted net loss per share of Common Stock attributable to Common Stock stockholders because their effect was anti-dilutive as of December 31:

	2023	2022
Shares issuable upon conversion of SPA Notes and settlement of make-whole provisions	42,768,078	725,514
Shares issuable upon exercise of SPA Warrants	556,205	1,443,555
Other warrants	9,139,280	442,747
Stock-based compensation awards – Options	31,897	148,698
Stock-based compensation awards – RSUs	115,361	74,457
Public warrants	98,088	98,088
Private warrants	464	464
Total	52,709,373	2,933,523